Free Trial
NYSE:ELV

Elevance Health Q3 2025 Earnings Report

Elevance Health logo
$313.90 -1.87 (-0.59%)
Closing price 03:59 PM Eastern
Extended Trading
$315.25 +1.35 (+0.43%)
As of 04:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Elevance Health EPS Results

Actual EPS
N/A
Consensus EPS
$5.03
Beat/Miss
N/A
One Year Ago EPS
N/A

Elevance Health Revenue Results

Actual Revenue
N/A
Expected Revenue
$49.26 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Elevance Health Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
Thursday, October 16, 2025
Conference Call Time
8:30AM ET

Conference Call Resources

Elevance Health Earnings Headlines

Elevance Health (ELV) Receives a Buy from Bernstein
$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.tc pixel
See More Elevance Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Elevance Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Elevance Health and other key companies, straight to your email.

About Elevance Health

Elevance Health (NYSE:ELV) (NYSE: ELV), formerly known as Anthem, Inc., is a leading health benefits company headquartered in Indianapolis, Indiana. The company operates through its affiliated health plans to offer a range of medical, pharmacy, dental, vision and other complementary benefits to individuals, employers, Medicaid and Medicare members. Elevance Health’s portfolio includes fully insured and self-funded plans, and it leverages partnerships with health systems and care providers to deliver coordinated care and wellness programs.

Central to Elevance Health’s services is its focus on leveraging data analytics and digital platforms to improve member engagement and health outcomes. The company’s IngenioRx pharmacy benefits manager provides prescription drug solutions, while its Value-Based Products and Partnerships segment aligns incentives with providers to manage costs and enhance quality of care. Elevance Health also offers telehealth services, care management, and population health programs designed to address chronic conditions and preventive care needs.

With operations spanning all 50 states and the District of Columbia, Elevance Health serves tens of millions of members through its affiliated Blue Cross and Blue Shield licensees. The company maintains strategic relationships with community health centers and local providers to ensure access to care in urban and rural markets alike. Elevance Health also supports various community initiatives focused on health equity, behavioral health, and social determinants of health.

Elevance Health is led by President and Chief Executive Officer Gail Boudreaux, who joined the company in 2017. Under her leadership, the company has pursued a transformation strategy aimed at enhancing consumer experience, modernizing technology infrastructure, and expanding value-based care arrangements. Elevance Health’s board of directors and executive team bring extensive experience in healthcare administration, finance and public policy, guiding the company as it navigates a dynamic regulatory environment and evolving industry trends.

View Elevance Health Profile

More Earnings Resources from MarketBeat